MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature

Antibodies to human full-length myelin oligodendrocyte glycoprotein (MOG-IgG) as detected by new-generation cell-based assays have recently been described in patients presenting with acute demyelinating disease of the central nervous system, including patients previously diagnosed with multiple scle...

Full description

Saved in:
Bibliographic Details
Main Authors: Jarius, Sven (Author) , Haas, Jürgen (Author) , Wildemann, Brigitte (Author)
Format: Article (Journal)
Language:English
Published: 19 March 2018
In: Journal of neuroinflammation
Year: 2018, Volume: 15
ISSN:1742-2094
DOI:10.1186/s12974-018-1108-6
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12974-018-1108-6
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12974-018-1108-6
Get full text
Author Notes:S. Jarius, K. Ruprecht, J.P. Stellmann, A. Huss, I. Ayzenberg, A. Willing, C. Trebst, M. Pawlitzki, A. Abdelhak, T. Grüter, F. Leypoldt, J. Haas, I. Kleiter, H. Tumani, K. Fechner, M. Reindl, F. Paul and B. Wildemann
Search Result 1

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature by Jarius, Sven (Author) , Haas, Jürgen (Author) , Wildemann, Brigitte (Author) ,

BioMed Central 19 March 2018

Get full text
Article (Journal) Book/Monograph Online Resource